Dementia Clinical Care in Relation to COVID-19.
Alzheimer’s disease
COVID-19
Dementia
Frailty
Long-term care
Journal
Current treatment options in neurology
ISSN: 1092-8480
Titre abrégé: Curr Treat Options Neurol
Pays: United States
ID NLM: 9815940
Informations de publication
Date de publication:
2022
2022
Historique:
accepted:
18
10
2021
pubmed:
1
3
2022
medline:
1
3
2022
entrez:
28
2
2022
Statut:
ppublish
Résumé
This review discusses the complex relationship between COVID-19 and dementia and how the pandemic has affected the management of patients with dementia. This population resulted particularly susceptible to SARS-CoV-2 infection and its effects and also to the negative effects of the measures taken worldwide to control the spread of the virus. Patients with dementia were at increased risk for COVID-19 compared to patients without dementia, and diagnosis of dementia represents an independent risk factor for hospitalization in COVID-19 patients. Mortality due to SARS-CoV2 infection in subjects with dementia is 2-5 times higher than in the general population. Cognitive impairment and delirium have been described in COVID-19 survivors. SARS-COV2 pandemic exacerbates the vulnerability of dementia patients and their caregivers, due to the morbidity and mortality from COVID-19, the indirect effects of the pandemic on the social supports, and the effects on healthcare system on which they depend. The COVID-19 pandemic requires people with dementia to move from traditional models of health care to innovative models for home care, to support caregivers' burden, and to improve long term care.
Identifiants
pubmed: 35221646
doi: 10.1007/s11940-022-00706-7
pii: 706
pmc: PMC8863507
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1-15Informations de copyright
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.
Déclaration de conflit d'intérêts
Conflict of InterestAngelo Bianchetti declares that he has no conflict of interest. Renzo Rozzini declares that he has no conflict of interest. Luca Bianchetti declares that he has no conflict of interest. Flaminia Coccia declares that she has no conflict of interest. Fabio Guerini declares that he has no conflict of interest. Marco Trabucchi declares that he has no conflict of interest.
Références
Alzheimers Dement. 2021 Aug;17(8):1297-1306
pubmed: 33559975
Age Ageing. 2019 Jul 1;48(4):485-488
pubmed: 30927352
Front Psychiatry. 2020 Nov 12;11:586686
pubmed: 33262713
J Alzheimers Dis. 2020;76(2):475-479
pubmed: 32651326
Age Ageing. 2021 Sep 11;50(5):1436-1438
pubmed: 34174069
Int J Geriatr Psychiatry. 2020 Jan;35(1):12-28
pubmed: 31617247
Lancet. 2021 Feb 27;397(10276):777-778
pubmed: 33607000
Intensive Care Med. 2021 Oct;47(10):1089-1103
pubmed: 34401939
J Pers Med. 2021 Jul 29;11(8):
pubmed: 34442390
J Alzheimers Dis. 2020;76(2):481-489
pubmed: 32651328
Front Public Health. 2020 Nov 02;8:556789
pubmed: 33224912
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e38-e45
pubmed: 33216846
Age Ageing. 2021 Feb 26;50(2):279-283
pubmed: 33320183
Alzheimers Res Ther. 2021 Jun 12;13(1):111
pubmed: 34118974
JAMA Intern Med. 2021 Apr 1;181(4):439-448
pubmed: 33394006
Redox Biol. 2021 May;41:101938
pubmed: 33730676
J Am Geriatr Soc. 2021 Feb;69(2):293-299
pubmed: 33411332
J Nutr Health Aging. 2020;24(6):560-562
pubmed: 32510106
Front Aging Neurosci. 2021 Apr 20;13:653533
pubmed: 33967740
Am J Geriatr Psychiatry. 2020 Nov;28(11):1175-1184
pubmed: 32873496
Aging Clin Exp Res. 2020 Sep;32(9):1883-1888
pubmed: 32654005
Int J Geriatr Psychiatry. 2020 Jul;35(7):803-805
pubmed: 32363628
Front Psychiatry. 2020 Sep 09;11:578015
pubmed: 33033486
J Am Geriatr Soc. 2021 Sep;69(9):2419-2429
pubmed: 34048599
Ir J Psychol Med. 2021 Sep;38(3):208-213
pubmed: 32460926
Neurology. 2020 Jan 7;94(1):30-38
pubmed: 31801829
Ther Adv Psychopharmacol. 2020 Jul 20;10:2045125320942703
pubmed: 32733668
Front Psychiatry. 2020 Sep 30;11:578465
pubmed: 33132938
EClinicalMedicine. 2021 Jan 07;31:100683
pubmed: 33490928
Front Public Health. 2021 Mar 16;9:662617
pubmed: 33796502
J Am Med Dir Assoc. 2020 Jul;21(7):928-932.e1
pubmed: 32674821
Sleep Med. 2020 Jun;70:111
pubmed: 32361215
Cochrane Database Syst Rev. 2020 Feb 28;2:CD012670
pubmed: 32108325
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
J Alzheimers Dis. 2021;82(3):883-898
pubmed: 34092646
Biomed Res Int. 2020 Nov 4;2020:8870249
pubmed: 33204723
Front Psychiatry. 2020 Oct 26;11:585373
pubmed: 33192731
J Alzheimers Dis. 2020;78(4):1775-1782
pubmed: 33285638
J Mol Neurosci. 2021 Nov;71(11):2192-2209
pubmed: 33464535
Int Psychogeriatr. 2020 Oct;32(10):1161-1164
pubmed: 32307030
Front Aging Neurosci. 2021 Apr 30;13:626127
pubmed: 33994990
Psychogeriatrics. 2020 Sep;20(5):792-793
pubmed: 32510762
CMAJ. 2021 Mar 15;193(11):E371-E377
pubmed: 33722828
J Psychosom Res. 2021 Feb;141:110350
pubmed: 33401078
Aging Clin Exp Res. 2020 Oct;32(10):2133-2140
pubmed: 32918696
Alzheimers Res Ther. 2021 Jun 9;13(1):110
pubmed: 34108016
J Neurol Sci. 2020 Sep 15;416:117013
pubmed: 32659508
Lancet. 2020 Apr 11;395(10231):1190-1191
pubmed: 32240625
Arch Gerontol Geriatr. 2021 Jul-Aug;95:104388
pubmed: 33713880
Neuropsychopharmacology. 2021 Dec;46(13):2235-2240
pubmed: 33589778
Front Psychiatry. 2020 Oct 14;11:586524
pubmed: 33173526
Lancet Psychiatry. 2020 May;7(5):387-388
pubmed: 32353267
Am J Geriatr Psychiatry. 2021 Jan;29(1):27-34
pubmed: 33153872
J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2224-2230
pubmed: 32687551
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Mol Neurobiol. 2021 Mar;58(3):1017-1023
pubmed: 33078369
J Am Geriatr Soc. 2020 Aug;68(8):1666-1670
pubmed: 32557533
Arch Gerontol Geriatr. 2021 Mar-Apr;93:104299
pubmed: 33285424
Aging (Albany NY). 2020 Jun 19;12(12):11238-11244
pubmed: 32561692
J Am Geriatr Soc. 2021 Aug;69(8):2063-2069
pubmed: 33861873
Transl Neurodegener. 2021 Apr 30;10(1):15
pubmed: 33941272
MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):632-638
pubmed: 33914721
Am J Geriatr Psychiatry. 2020 Jul;28(7):712-721
pubmed: 32331845